NVSEF
What one share of Novartis AG holds
Pharmaceutical Preparations
Novartis AG’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Profit | $7.15 |
|---|---|
| Capex (buildings and equipment) | $0.79 |
| Free cash flow | $9.00 |
| Dividends | $4.00 |
| Cash and investments | $5.99 |
| Debt | $15.06 |
| Book value | $24.18 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | — | $2.80 | $0.78 | $4.01 | — | $31.55 |
| 2017 | — | $3.25 | $0.56 | $4.76 | — | $32.00 |
| 2018 | — | $5.38 | $0.54 | $5.55 | — | $34.01 |
| 2019 | — | $5.06 | $0.59 | $5.28 | — | $24.49 |
| 2020 | — | $3.52 | $0.56 | $5.39 | — | $25.08 |
| 2021 | — | $10.63 | $0.47 | $6.20 | — | $30.27 |
| 2022 | — | $3.17 | $0.42 | $6.06 | — | $28.00 |
| 2023 | — | $7.10 | $0.51 | $6.40 | — | $22.83 |
| 2024 | — | $5.87 | $0.67 | $7.99 | — | $22.30 |
| 2025 | — | $7.15 | $0.79 | $9.00 | — | $24.18 |